Andreas Kupsch
Andreas Kupsch
Dpt of Neurology and Stereotactic Neurosurgery
Verified email at
Cited by
Cited by
A randomized trial of deep-brain stimulation for Parkinson's disease
G Deuschl, C Schade-Brittinger, P Krack, J Volkmann, H Schäfer, K Bötzel, ...
New England Journal of Medicine 355 (9), 896-908, 2006
Neurostimulation for Parkinson's disease with early motor complications
WMM Schuepbach, J Rau, K Knudsen, J Volkmann, P Krack, ...
New England Journal of Medicine 368 (7), 610-622, 2013
Pallidal deep-brain stimulation in primary generalized or segmental dystonia
A Kupsch, R Benecke, J Müller, T Trottenberg, GH Schneider, W Poewe, ...
New England Journal of Medicine 355 (19), 1978-1990, 2006
Reduction in subthalamic 8–35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease
AA Kühn, A Kupsch, GH Schneider, P Brown
European Journal of Neuroscience 23 (7), 1956-1960, 2006
High-frequency stimulation of the subthalamic nucleus suppresses oscillatory β activity in patients with Parkinson's disease in parallel with improvement in motor performance
AA Kühn, F Kempf, C Brücke, LG Doyle, I Martinez-Torres, A Pogosyan, ...
Journal of Neuroscience 28 (24), 6165-6173, 2008
Event‐related beta desynchronization in human subthalamic nucleus correlates with motor performance
AA Kühn, D Williams, A Kupsch, P Limousin, M Hariz, GH Schneider, ...
Brain 127 (4), 735-746, 2004
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study
K Witt, C Daniels, J Reiff, P Krack, J Volkmann, MO Pinsker, M Krause, ...
The Lancet Neurology 7 (7), 605-614, 2008
Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity
AA Kühn, A Tsui, T Aziz, N Ray, C Brücke, A Kupsch, GH Schneider, ...
Experimental neurology 215 (2), 380-387, 2009
Connectivity predicts deep brain stimulation outcome in P arkinson disease
A Horn, M Reich, J Vorwerk, N Li, G Wenzel, Q Fang, T Schmitz‐Hübsch, ...
Annals of neurology 82 (1), 67-78, 2017
The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease
AA Kühn, T Trottenberg, A Kivi, A Kupsch, GH Schneider, P Brown
Experimental neurology 194 (1), 212-220, 2005
Patterning of globus pallidus local field potentials differs between Parkinson’s disease and dystonia
P Silberstein, AA KuÈhn, A Kupsch, T Trottenberg, JK Krauss, JC WoÈhrle, ...
Brain 126 (12), 2597-2608, 2003
Dopamine depletion increases the power and coherence of β‐oscillations in the cerebral cortex and subthalamic nucleus of the awake rat
A Sharott, PJ Magill, D Harnack, A Kupsch, W Meissner, P Brown
European Journal of Neuroscience 21 (5), 1413-1422, 2005
Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells
A Storch, G Paul, M Csete, BO Boehm, PM Carvey, A Kupsch, J Schwarz
Experimental neurology 170 (2), 317-325, 2001
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial
J Volkmann, A Wolters, A Kupsch, J Müller, AA Kühn, GH Schneider, ...
The Lancet Neurology 11 (12), 1029-1038, 2012
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
P Brundin, O Pogarell, P Hagell, P Piccini, H Widner, A Schrag, A Kupsch, ...
Brain 123 (7), 1380-1390, 2000
Cortico-cortical coupling in Parkinson's disease and its modulation by therapy
P Silberstein, A Pogosyan, AA Kühn, G Hotton, S Tisch, A Kupsch, ...
Brain 128 (6), 1277-1291, 2005
Comparing exercise in Parkinson's disease—the Berlin BIG Study
G Ebersbach, A Ebersbach, D Edler, O Kaufhold, M Kusch, A Kupsch, ...
Movement disorders 25 (12), 1902-1908, 2010
Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial
J Volkmann, J Mueller, G Deuschl, AA Kühn, JK Krauss, W Poewe, ...
The Lancet Neurology 13 (9), 875-884, 2014
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy
E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ...
Movement Disorders 29 (4), 470-478, 2014
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson disease
A Storch, WH Jost, P Vieregge, J Spiegel, W Greulich, J Durner, T Müller, ...
Archives of neurology 64 (7), 938-944, 2007
The system can't perform the operation now. Try again later.
Articles 1–20